Trending Topics

Loading trending topics...

See what’s trending right now
8 hours ago

The U.S. grapples with fentanyl crisis as funding for overdose programs faces delays and penalties for smuggling are tightened, but $140 million in allocated funds remains withheld, creating uncertainty in the response.

Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease

ABC NewsWednesday, July 16, 2025 at 9:18:22 PM
PositiveHealthGenetic Medicine
Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease
In a groundbreaking medical achievement, eight healthy babies have been born in the UK using an experimental technique that combines DNA from three people—two parents and a donor—to prevent mothers from passing on rare genetic diseases to their children. Scientists say this could be a game-changer for families at risk of transmitting mitochondrial disorders.
Editor’s Note: This isn’t just another science headline—it’s a real-world leap forward for families who’ve faced the heartbreak of losing children to incurable genetic conditions. By tweaking how embryos are created, researchers are offering hope where there was none before. Sure, there are ethical debates (messing with DNA always sparks those), but for parents who’ve endured the pain of these diseases, it’s a lifeline. The success of these births could pave the way for wider use, reshaping how we tackle inherited illnesses.
— Curated via WP Now’s

Was this article worth reading? Share it

Latest from Health
F.D.A. Panel to Reassess Hormone Therapy Warnings
NeutralHealth
A panel of experts advising the U.S. Food and Drug Administration (FDA) is taking another look at the safety warnings tied to hormone replacement therapy (HRT) for menopause. The therapy, which helps ease symptoms like hot flashes, has been controversial for years due to links to increased risks of breast cancer and heart disease. Now, new research and evolving medical perspectives might lead to updated guidelines—potentially refining who should use HRT and for how long.
Editor’s Note: If you or someone you know has grappled with menopause symptoms, this story matters. The FDA’s reassessment could shift how doctors prescribe hormone therapy, balancing real risks against the relief it provides. It’s part of an ongoing conversation about how women’s health issues are studied—and sometimes misunderstood. Changes here could mean clearer, more personalized advice for millions.
Health Care Roundup: Market Talk
NeutralHealth
The latest health care market roundup dives into updates on big pharma players like Novartis and Johnson & Johnson, giving investors and industry watchers a snapshot of how these companies are performing and what trends might be shaping the sector. Think of it as a quick pulse check on who’s up, who’s down, and why it matters.
Editor’s Note: Whether you’re tracking stocks, work in health care, or just want to stay informed about the companies behind major drugs and treatments, this kind of update helps connect the dots between corporate moves and real-world impact. It’s not flashy, but it’s the kind of behind-the-scenes insight that keeps professionals—and curious readers—in the loop.
Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price
PositiveHealth
Big pharma players Bristol-Myers Squibb and Pfizer are shaking things up by offering their blockbuster blood thinner Eliquis directly to patients—no insurance middleman—at a lower cash price. This move comes after talks with the Trump administration, suggesting a push to sidestep traditional drug pricing hurdles.
Editor’s Note: If you’ve ever winced at pharmacy prices, this could be a game-changer. Cutting out insurers might mean real savings for some patients, especially those paying out of pocket. But it also raises questions: Will this model pressure insurers to lower costs, or is it just a workaround for a broken system? Either way, it’s a sign that drug pricing—a hot-button issue—is ripe for disruption.
The mother of an L.A. teen who took his own life is fighting for a new mental health tool for LGBTQ+ youth
NeutralHealth
A grieving mother in Los Angeles is pushing for a new California law that would require student IDs to include a crisis hotline specifically for LGBTQ+ youth. Her teenage son died by suicide, and she’s now advocating for better mental health support after the Trump administration removed an LGBTQ+ option from the national suicide prevention lifeline.
Editor’s Note: This story hits hard because it’s about a parent turning personal tragedy into action—trying to prevent other families from suffering the same loss. It also highlights how policy decisions (like cutting specialized crisis services) can have real, life-or-death consequences for vulnerable groups. If passed, this small change—a number on a student ID—could be a lifeline for struggling LGBTQ+ teens.
My Memory Loss Is Affecting My Relationship
NegativeHealth
A reader struggling with memory loss writes to therapist Lori Gottlieb, concerned that their spouse isn't responding with enough understanding. Gottlieb’s advice likely explores how to bridge this emotional gap—both for the person experiencing cognitive changes and their partner navigating this challenge together.
Editor’s Note: Memory issues don’t just affect the individual—they ripple into relationships, often testing patience and empathy. This column taps into a quiet but common struggle: how to ask for (and offer) support when something as fundamental as recall starts to slip. It’s a reminder that compassion is a two-way street, even in the messiest moments.

Why World Pulse Now?

Global Coverage

All major sources, one page

Emotional Lens

Feel the mood behind headlines

Trending Topics

Know what’s trending, globally

Read Less, Know More

Get summaries. Save time

Stay informed, save time
Learn more

Live Stats

Articles Processed

7,851

Trending Topics

153

Sources Monitored

204

Last Updated

28 minutes ago

Live data processing
How it works

Mobile App

Available on iOS & Android

The mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.

Get it on Google PlayDownload on the App Store
Available now on iOS and Android

1-Minute Daily Briefing

Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more

By subscribing, you agree to our Privacy Policy